Top Life Sciences Startups in 2027

WHO WE ARE : We are a team of seasoned executives and entrepreneurs, who have deep experience working in both the US and China. We are highly technical, with 7 PhDs and over 150 patents filed among our investment team. WHAT WE DO : We invest in early stage technology companies and help them grow. WHERE WE EXCEL: We are deeply technical, and skilled at evaluating emerging technologies. We are able to fully leverage connections between China and the US for funding, market development, and exit opportunities.

We are a life sciences consultancy that wishes to acquire a brand new factory previously owned by a major pharmaceutical company to make cancer drugs for clinical studies. This business would operate as a contract manufacturing operation (CMO), specializing in cytotoxic or highly potent compounds. Oncology is a lucrative part of the life sciences industry, and has more growth potential then the rest of the categories in pharmaceuticals. The funding is strictly for the assets, we will bring the sweat equity to get the facility commissioned, qualified and validated to Food and Drug Administration Standards as well as well as European Medicines Agency Standards.

Infinote is offers a one-click Big Data Analytics solution for text-based content, enabling real-time Compliance and Change Control.

PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading-edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community.

Natera® is a worldwide genetic testing and diagnostics company that’s changing how doctors and patients manage genetic disease. Our team includes clinicians, scientists, biostatisticians, researchers, and talented laboratory professionals from around the globe. Natera develops and commercializes non-invasive methods for analyzing DNA. We operate a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California, and offer a host of proprietary genetic testing services. Specialties: Non-Invasive Prenatal Testing (NIPT), Single Gene Diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy Training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage Testing, Genetic Counseling, Non-Invasive Paternity Testing, and Genetics Hours:9am-5pm PST, Monday-Friday Address: 201 Industrial Road Suite 410 San Carlos, CA 94070 Phone: (650) 249-9090 Email: [email protected]

Aidoc is the market leader in Healthcare AI. We deliver the most widely used portfolio of AI solutions to help physicians prioritize life threatening cases and improve patient outcomes. Aidoc’s solutions are in use in over 900 hospitals including the leading health systems in the US. Aidoc is funded by top VCs, having raised more than $250 million to date, and was chosen as one of TIME’s 50 most genius companies.

Venipuncture is the most common invasive medical procedure, with over 1.4B procedures performed annually in the US alone. It is also one of the most overlooked problems in medicine. 20% of first attempts to gain access to a vein fail, often leading to patient complications and additional expenses for medical facilities. Veebot is automating venipuncture through computer vision and robotics, making it safer for both patients and medical staff, and cost efficient for medical facilities.

We develop and sell medical navigation technology that assists surgeons during orthopedic surgeries, specifically hip replacements.

The Walgreens Pharmacy Renewal efforts seek to design and build the largest, most advanced pharmacy infrastructure in the world from the ground up. Empowered to operate as an innovation center, this effort represents one of Walgreens most important programs at both global and local levels. US, UK and Italy based teams will be leveraging the most advanced and exciting technologies to build on Walgreens strategic vision to service the 13,100 plus pharmacy-led, health and wellbeing retails stores Worldwide.

Our physics-based computational platform integrates differentiated solutions for predictive modeling, data analytics, and collaboration to enable rapid exploration of chemical space. The Schrödinger platform is deployed by industry leaders worldwide for drug discovery, as well as for materials science in fields as diverse as aerospace, energy, semiconductors, oil and gas, automotive, and electronics displays. The platform also powers our own drug discovery efforts, from target identification to hit discovery to lead optimization. It also drives our research collaborations to develop novel medicines for critical public health needs. With more than 150 Ph.D. scientists on our team, we invest heavily in R&D. We’ve published over 400 peer-reviewed papers that demonstrate the strength of our physics-based approaches, and we’re continually pushing the limits of computer modeling.